What is ALZN stock price today?

ALZN (Alzamend Neuro Inc) stock is trading at $2.14 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ALZN stock going up or down today?

ALZN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ALZN stock now?

The decision to buy ALZN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ALZN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ALZN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ALZN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ALZN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ALZN's P/E ratio?

P/E ratio data for ALZN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ALZN's market cap?

ALZN (Alzamend Neuro Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is ALZN's price to book ratio?

ALZN trades at a price-to-book (P/B) ratio of 1.90, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ALZN pay dividends?

ALZN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ALZN's dividend yield?

ALZN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ALZN stock a good long-term investment?

ALZN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ALZN's revenue growth rate?

Revenue growth data for ALZN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ALZN are available on our dashboard with complete income statement analysis.

What are the risks of investing in ALZN?

Key risks for ALZN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ALZN compare to its competitors?

Compare ALZN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ALZN's performance and positioning.

What is ALZN's stock price target for 2026?

Our AI model provides price targets for ALZN based on fundamental analysis: Bull case $2.78 (+30%), Base case $2.46 (+15%), Bear case $1.93 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ALZN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ALZN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ALZN's next earnings report?

ALZN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ALZN - Alzamend Neuro Inc

NYSE * Health Care * Biotechnology

$2.14

+$0.04 (+1.90%)

About Alzamend Neuro Inc

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

ALZN Key Statistics

Market Cap

$7.99M

P/B Ratio

1.90

EPS

$-2.67

Employees

How ALZN Compares to Peers

ALZN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ALZN(This stock)	$7.99M	N/A	0%	0.0%	-
AMGNAmgen Inc	$198.26B	25.8	0%	0.2%	vs AMGN
GILDGilead Sciences	$180.27B	21.4	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$121.45B	31.2	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.93B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$27.14B	21.1	-0%	0.1%	vs BIIB

Alzamend Neuro Inc Company Information

Headquarters: Florida; U.S.A
Website: www.alzamend.com
Sector: Health Care
Industry: Biotechnology

Data Updated: March 13, 2026 at 9:28 AM EDT

Ready to invest in ALZN?

Commission-free trading available. Affiliate links.

ALZN Lician Score

5% confidence

4.0/10

Neutral

ALZN has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ALZNacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ALZN Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ALZN

Dashboard

Enter a ticker to analyze